"There’s no new evidence suggesting any safety or efficacy concerns," says Dr. Ben Lopman, Director of CIDMATH. "This shift reflects a political decision that runs counter to the views of vaccine scientists and public health experts." #vaccines #publichealth

Authors include CIDMATH investigators Kristin Nelson, Samuel Jenness, and Ben Lopman, staff Machi Shiiba, doctoral students Sara S. Kim and Pragati Prasad, and collaborators

Code and data are accessible here: github.com/lopmanlab/Gl...

Full paper here: journals.plos.org/ploscompbiol...

At CIDMATH, innovation is not only about developing new methods, techniques, and platforms in modeling & analytics, but ensuring #PublicHealth professionals are equipped with the skills needed to tackle infectious disease challenges.

CIDMATH investigator Dr. Max Lau is pioneering #machinelearning approaches to forecast disease trends and inform public health planning. Swipe to learn more!

CIDMATH’s partnership with Kaiser Permanente Georgia facilitates the use of existing medical records for this study. Learn more on CIDMATH.org! (2/2) #vaccines #RSV

Led by Dr. Kristin Nelson and Dr. Sharia Ahmed, in partnership with Kaiser Permanente Georgia and Georgia CTSA, CIDMATH is conducting two studies to gain new insights into social contact patterns to help prevent the spread of #infectiousdiseases

This post reflects confirmed case numbers as of 4/4/25 and reported hospitalizations and deaths as of 4/8/25. Outbreak numbers change rapidly. For the latest, you can check cdc.gov/measles for updates every Friday, and the Texas DSHS for updates on Tuesdays and Fridays.

Two doses of the MMR vaccine are 97% effective at preventing measles. U.S. #MMR coverage among kindergartners is below the 95% coverage target and on the decline. Decreasing vaccination coverage increases the risk of vaccine-preventable disease outbreaks like this one.

(2/2) For more information: cdc.gov/bird-flu